Loading clinical trials...
Loading clinical trials...
A Modular Phase I/II, Open-Label, Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies
Conditions
Interventions
AZD0466
Voriconazole
Locations
15
United States
Research Site
Duarte, California, United States
Research Site
Jacksonville, Florida, United States
Research Site
Chicago, Illinois, United States
Research Site
Columbus, Ohio, United States
Research Site
Houston, Texas, United States
Research Site
Melbourne, Australia
Start Date
June 11, 2021
Primary Completion Date
August 8, 2023
Completion Date
August 8, 2023
Last Updated
June 15, 2025
NCT06805097
NCT06797037
NCT03263637
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions